Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUP

Rank in Stocks #27582
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Share Price
$2.55
Last synced: 2026-11-13
Market Cap
$13.80M
Change (1 day)
-1.16%
Change (1 year)
-42.83%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Neuphoria Therapeutics Inc. (NEUP)

Category

Healthcare
Operating Margin for Neuphoria Therapeutics Inc. (NEUP)
Operating Margin as of November 2026 TTM: -1,187.73%
According to Neuphoria Therapeutics Inc.'s latest financial reports, its current operating margin (TTM) is -1,187.73%. At the end of 2025 the company had an operating margin of -7.21%.
Operating Margin history for Neuphoria Therapeutics Inc. from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -1,187.73% 16,373.37%
2025 -7.21% 0.00%
2024 0.00% 0.00%
2023 0.00% -100.00%
2022 -10,292.00% 0.00%
2021 0.00% -100.00%
2020 -25,865.53% 810.98%
2019 -2,839.32% 267.90%
2018 -771.76% 912.68%
2017 -76.21% -79.03%
2016 -363.49% -7.76%
2015 -394.06% 1,899.29%
2014 -19.71% -97.85%
2013 -918.27% 506.08%
2012 -151.51% -58.24%
2011 -362.77% -42.10%
2010 -626.55% 31.16%
2009 -477.69% -59.28%
2008 -1,173.12% -6.21%
2007 -1,250.74% -10.77%
2006 -1,401.76% -44.46%
2005 -2,523.87% 0.00%
2004 -2,523.87% 556.97%
2003 -384.17% 103.70%
2002 -188.60% -3.45%
2001 -195.33% 0.00%
2000 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -99.84%
US
33.87% -100.03%
US
-116.04% -99.90%
US
25.57% -100.02%
AU
31.23% -100.03%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Neuphoria Therapeutics Inc.'s operating margin

What is Neuphoria Therapeutics Inc.'s operating margin?

Neuphoria Therapeutics Inc.'s operating margin is -1,187.73%, as of Nov 2026.

What was Neuphoria Therapeutics Inc.'s operating margin in 2025?

In 2025, Neuphoria Therapeutics Inc.'s operating margin was -7.21%, compared with 0.00% in 2024.

How has Neuphoria Therapeutics Inc.'s operating margin changed since 2020?

From 2020 to 2025, Neuphoria Therapeutics Inc.'s operating margin was highest in 2024 (0.00%) and lowest in 2020 (-25,865.53%).

How does Neuphoria Therapeutics Inc.'s operating margin compare with similar companies?

Neuphoria Therapeutics Inc.'s operating margin (-1,187.73%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.